Changeflow GovPing Government & Legislation Therapeutic Goods Serious Scarcity Clonidine Am...
Priority review Rule Amended Final

Therapeutic Goods Serious Scarcity Clonidine Amendment Instrument 2026

Favicon for www.legislation.gov.au AU Federal Legislative Instruments (7-day)
Published
Detected
Email

Summary

The Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Amendment Instrument 2026 (F2026L00447) amends the 2025 clonidine scarcity instrument. The amendment, registered on 23 April 2026 and currently in force, is administered by the Australian Department of Health, Disability and Ageing. The instrument likely modifies provisions governing substitutable medicines during periods of serious scarcity of clonidine, a prescription medication used for hypertension and ADHD.

Published by DoH on legislation.gov.au . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors AU Federal Legislative Instruments (7-day) for new government & legislation regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 223 changes logged to date.

View original document View source feed page

What changed

This instrument amends the Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Instrument 2025 by modifying provisions related to substitutable medicines during periods of serious clonidine scarcity. The amendment, registered as F2026L00447, took effect on 23 April 2026.

Healthcare providers, pharmacists, and pharmaceutical suppliers should review the updated substitution provisions to ensure compliance with current clonidine scarcity management requirements. Patients relying on clonidine may be affected by changes to authorised substitute medicines during the scarcity period.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

- Interactions

Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Amendment Instrument 2026

In force Administered by
- Department of Health, Disability and Ageing
Latest version F2026L00447 23 April 2026

View document Legislative instrument Explanatory statement Filter active Table of contents
- 1 Name
- 2 Commencement
- 3 Authority
- 4 Schedules
- Schedule 1—Amendments
- Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Instrument 2025

Named provisions

Name Commencement Authority Schedules

Related changes

Favicon for anzctr.org.au Respiratory Muscle Training Trial, ANZCTR, Spain, Recruiting
Routine Apr 23, 2026 • ANZCTR - Clinical Trial Search • Healthcare & Life Sciences
Favicon for anzctr.org.au Prostate Cancer Brachytherapy Trial, NSW, Recruiting
Routine Apr 23, 2026 • ANZCTR - Clinical Trial Search • Healthcare & Life Sciences
Favicon for www.legislation.gov.au Military Rehabilitation and Compensation (Non-warlike Service) Determination 2019
Routine Apr 23, 2026 • AU Federal Legislative Instruments (7-day) • Government & Legislation

Get daily alerts for AU Federal Legislative Instruments (7-day)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Source

Favicon for www.legislation.gov.au
AU Federal Legislative Instruments (7-day) legislation.gov.au/search/registrationdate(today-7,today)/collection(LegislativeInstrument)/sort(registeredat%20desc)
Government & Legislation

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DoH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Press inquiries →

Classification

Agency
DoH
Published
April 23rd, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
F2026L00447
Supersedes
Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Clonidine) Instrument 2025

Who this affects

Applies to
Healthcare providers Pharmaceutical companies Patients
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug scarcity management Medicine substitution
Geographic scope
Australia AU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Compliance frameworks
GxP
Topics
Public Health Healthcare

Browse Categories

Agriculture & Food Safety 80 AI Regulation 3 Banking & Finance 475 Consumer Protection 118 Courts & Legal 450 Data Privacy & Cybersecurity 134 Defense & National Security 52 Education 64 Energy 113 Environment 164 Gaming 2 Government & Legislation 470 Healthcare 15 Healthcare & Life Sciences 374 Immigration 11 Insurance 86 Labor & Employment 182 Pharma & Drug Safety 21 Professional Licensing 6 Real Estate & Housing 73 Securities & Markets 169 Tax 104 Telecom & Technology 50 Trade & Sanctions 159 Transportation 115

Get alerts for this source

We'll email you when AU Federal Legislative Instruments (7-day) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!